Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
KalVista Pharmaceuticals, Inc. (KALV) had Non-Operating Income/Expense of $13.80M for the most recently reported fiscal year, ending 2024-04-30.
| Income Statement Financials | |
-- |
|
$-126.64M |
|
-- |
|
-- |
|
$140.44M |
|
$-140.44M |
|
|
Non-Operating Income/Expense |
$13.80M |
$-126.64M |
|
$-126.64M |
|
$-126.64M |
|
$-126.64M |
|
$-126.64M |
|
$-126.64M |
|
$-140.44M |
|
$-139.54M |
|
36.79M |
|
36.79M |
|
$-3.44 |
|
$-3.44 |
|
| Balance Sheet Financials | |
$225.69M |
|
$2.23M |
|
$9.71M |
|
$235.40M |
|
$22.81M |
|
-- |
|
$6.01M |
|
$28.82M |
|
$206.58M |
|
$206.58M |
|
$206.58M |
|
42.52M |
|
| Cash Flow Statement Financials | |
$-89.23M |
|
$-84.72M |
|
$150.71M |
|
$56.24M |
|
$31.79M |
|
$-24.45M |
|
$21.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-89.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-61.30% |
|
-61.30% |
|
-53.80% |
|
-61.30% |
|
$4.86 |
|
$-2.44 |
|
$-2.43 |
|